Literature DB >> 15062595

Pathologic characteristics of drug-induced lung disease.

Douglas B Flieder1, William D Travis.   

Abstract

The surgical pathologist's role in the diagnosis of adverse pulmonary and pleural drug effect requires an appreciation of the clinico-radiologic scenario and particular knowledge of morphologic patterns of lung injury. Bronchoscopic biopsies may be helpful in some cases of DAD, eosinophilic pneumonia, or OP. Extrapolating patterns of lung involvement from small biopsies and cytologic preparations often is difficult and surgical lung biopsy is required. Although lung biopsies are not pathognomonic for drug toxicity and correlation with clinical, laboratory, and radiologic data is required, they can be a powerful tool in the evaluation of suspected drug-induced pulmonary disease by helping to exclude underlying disease or infection and documenting the pattern of lung injury. The latter information is helpful in making the diagnosis of drug toxicity as well as guiding the optimal management of the patient.

Entities:  

Mesh:

Year:  2004        PMID: 15062595     DOI: 10.1016/S0272-5231(03)00138-2

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  25 in total

1.  Granulomatous interstitial pneumonia induced by the intake of rice bran pickles: a rare subtype of pulmonary manifestation associated with food allergy.

Authors:  Yoshiaki Kinoshita; Atsuhiko Sakamoto; Shinichi Aishima; Kouko Hidaka
Journal:  BMJ Case Rep       Date:  2015-04-09

2.  S-1-induced lung injury combined with pneumocystis pneumonia.

Authors:  Shuichi Yano
Journal:  BMJ Case Rep       Date:  2013-02-04

3.  Amoxicillin-Induced Eosinophilic Pneumonia with Granulomatous Reaction: Discrepancy between Drug-Induced Lymphocyte Stimulation Test Findings and the Provocation Drug Test.

Authors:  Osamu Matsuno; Ryuichi Takenaka; Masaru Ando; Eishi Miyazaki; Tosihide Kumamoto
Journal:  Allergy Asthma Clin Immunol       Date:  2007-06-15       Impact factor: 3.406

4.  Diphenylhydantoin (phenytoin)-induced chronic pulmonary disease.

Authors:  Ramakant Dixit; Kalpana Dixit; Paras Nuwal; Arunima Banerjee; Sidharth Sharma; Lokendra Dave
Journal:  Lung India       Date:  2009-10

Review 5.  Pulmonary eosinophilia.

Authors:  Uriel Katz; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

6.  Mesalazine-induced lung fibrosis.

Authors:  Ebraheem Alskaf; Amer Aljoudeh; Frank Edenborough
Journal:  BMJ Case Rep       Date:  2013-04-09

7.  Epoprostenol-associated pneumonitis: diagnostic use of a T-cell proliferation assay.

Authors:  Kristina T Kudelko; Kari Nadeau; Ann N Leung; Juliana Liu; François Haddad; Roham T Zamanian; Vinicio De Jesus Perez
Journal:  J Heart Lung Transplant       Date:  2010-06-08       Impact factor: 10.247

8.  Drug induced interstitial lung disease.

Authors:  Martin Schwaiblmair; Werner Behr; Thomas Haeckel; Bruno Märkl; Wolfgang Foerg; Thomas Berghaus
Journal:  Open Respir Med J       Date:  2012-07-27

9.  Emergent high fatality lung disease in systemic juvenile arthritis.

Authors:  Gail H Deutsch; R Paul Guillerman; Johannes Birgmeier; Karthik Jagadeesh; Scott Canna; Grant Schulert; Vivian E Saper; Guangbo Chen; Robin Deterding; Jianpeng Xu; Ann N Leung; Layla Bouzoubaa; Khalid Abulaban; Kevin Baszis; Edward M Behrens; James Birmingham; Alicia Casey; Michal Cidon; Randy Q Cron; Aliva De; Fabrizio De Benedetti; Ian Ferguson; Martha P Fishman; Steven I Goodman; T Brent Graham; Alexei A Grom; Kathleen Haines; Melissa Hazen; Lauren A Henderson; Assunta Ho; Maria Ibarra; Christi J Inman; Rita Jerath; Khulood Khawaja; Daniel J Kingsbury; Marisa Klein-Gitelman; Khanh Lai; Sivia Lapidus; Clara Lin; Jenny Lin; Deborah R Liptzin; Diana Milojevic; Joy Mombourquette; Karen Onel; Seza Ozen; Maria Perez; Kathryn Phillippi; Sampath Prahalad; Suhas Radhakrishna; Adam Reinhardt; Mona Riskalla; Natalie Rosenwasser; Johannes Roth; Rayfel Schneider; Dieneke Schonenberg-Meinema; Susan Shenoi; Judith A Smith; Hafize Emine Sönmez; Matthew L Stoll; Christopher Towe; Sara O Vargas; Richard K Vehe; Lisa R Young; Jacqueline Yang; Tushar Desai; Raymond Balise; Ying Lu; Lu Tian; Gill Bejerano; Mark M Davis; Purvesh Khatri; Elizabeth D Mellins
Journal:  Ann Rheum Dis       Date:  2019-09-27       Impact factor: 19.103

Review 10.  The knowns & unknowns of pulmonary toxicity following immune checkpoint inhibitor therapies: a narrative review.

Authors:  Alistair R Miller; Renee Manser
Journal:  Transl Lung Cancer Res       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.